Proneurogen, Inc.
Organisation
People
17 Sept 2026reporter.nih.gov
17 Sept 2026reporter.nih.gov
Grants and prizes
Scale-up GMP Manufacturing of Extended-Release PNA5 for Treating Cognitive Impairment in Patients at-risk for Alzheimer's Disease-Related Dementias and Vascular DementiaR43AG099316US$499.8k17 Sept 2026reporter.nih.gov